Strategize with our Interventional Cardiologist Email List

Boost your business network & grow your ROI with our all-inclusive Licensed Practical Nurses Marketing Data

Why You Require Mailing Lists

If your goal is in executing effective marketing campaigns to reach the Licensed Practical Nurses of the world of medical & healthcare, it’s very important to have the necessary materials that can be relied on.

Our verified, validated & updated Licensed Practical Nurses Email Address that can equip you with the right marketing information regarding the targeted prospects for strategizing marketing campaigns that fetch results.

Our data analysts at MedicoLeads have compiled the Licensed Practical Nurses Address Database from a variety of authentic & reliable source, including state licensed data.

Attain your customized Customers Data of Licensed Practical Nurses as per your business needs to simplify your business communications.

Dr.Sunny Bhatia selected for the national list of physician leaders for their dedication to strengthening Prime Healthcare through their leadership in clinical excellence, operational strategy, patient-centered initiatives.Sunny Bhatia, MD.

CMO of Prime Healthcare Division I (Ontario, Calif.).

As CMO of Prime Healthcare Division I, Dr. Bhatia is responsible for the clinical affairs at the health system's 17 hospitals in California and Nevada.

He also serves as CMO of 99-bed Sherman Oaks (Calif.) Hospital and 150-bed Encino (Calif.) Hospital Medical Center, two of Prime Healthcare's acute care community hospitals.

He is board certified in four specialties: internal medicine, cardiovascular disease, nuclear cardiology and interventional cardiology.

Along with his leadership roles, Dr. Bhatia is involved in several charitable organizations, such as the Uganda HeartProject, which provides cardiac care to children with congenital heart disease.

According to the new market research report Interventional Cardiology Market size is projected to reach USD 21.2 billion by 2025 from USD 13.8 billion in 2020, at a CAGR of 8.9%.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548The Growth in the Interventional Cardiology Devices Market is driven mainly by the rapid growth in the geriatric population and the associated increase in the prevalence of coronary artery diseases, approval of new and advanced products, and the growing preference for minimally invasive surgeries.The old/normal balloons segment accounted for the largest share of the angioplasty balloons market in 2019.Based on type, the angioplasty balloons market is segmented into old/normal balloons, cutting and scoring balloons, and drug-eluting balloons.

In 2019, the old/normal balloons segment accounted for the largest share of the angioplasty balloons market.

The large share of this segment can be attributed to a increasing its use in impating the stents and structural heart devices; and increasing prevalence of vaulvuloplasty.Thrombectomy devices segment accounted for the largest share of the plaque modification devices market in 2019.Based on type, the plaque modification devices market is segmented into atherectomy devices and thrombectomy devices.

In 2019, the thrombectomy devices segment accounted for the largest share of the plaque modification devices market.

Growth in this market segment can largely be attributed to the increasing incidence of blood clots and atrial embolisms across the globe.North America accounted for the largest share of the interventional cardiology market in 2019.North America accounted for the largest share of the interventional cardiology market in 2019.

The large share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, the growing geriatric population, and the strong presence of industry players in the region.Opportunity: Emerging MarketsIndia, China, and Brazil are relatively untapped markets for interventional cardiology.

You can buy the comprehensive and accurate Public School Email List from the School Data Lists.

They provide the best in industry and new email lists of the public schools in the United States.  

Market HighlightsAccording to MRFR analysis, the Global Interventional Cardiology Market is expected to register a CAGR of 7.25% from 2019 to 2025 and held a value of USD 15,130.75 Million in 2018.The interventional cardiology market is driven by several factors, such as technological advancements in interventional cardiac devices, rising prevalence of cardiac diseases, increasing preference for minimally invasive procedures, and increasing geriatric population.

The Americas held maximum share in the base year 2018, owing to the high incidence rates of cardiac disorders and strategic activities by major players in countries such as the US.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The interventional cardiology market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.SegmentationThe Global Interventional Cardiology Market has been segmented based on Type, and End User.The market, based on type, has been segmented into stents, percutaneous transluminal coronary angioplasty (PTCA) catheters, plaque modification devices, coronary guidewires, and accessories.

The stents segment held a major share in 2018 owing to the increased number of product launches by key players in the current years.

This segment is also expected to be the fastest-growing segment during the forecast period due to the increasing prevalence of coronary artery disease, and continued innovations by players.

The global interventional cardiology devices market size was valued at USD 15.14 billion in 2013 and is anticipated to reach USD 25.16 billion by 2020.

Global interventional cardiology devices market is expected to experience brisk growth due to rise in heart related problems across the world over the forecast period.

Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems.

Several devices used in these procedures include stent, PTCA balloon and catheters among several others.

The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.

Research and development across the world for technological advancement in order to achieve competitive advantage is estimated to further fuel the market demand over the forecast period.

The Global Interventional Cardiology Market research study published by Emergen Research is an extensive collection of insightful information about the Interventional Cardiology industry.

The report covers the Interventional Cardiology Market segmentation along with a detailed outline of the Interventional Cardiology market size with regards to volume and valuation.

The report provides comprehensive coverage of the Interventional Cardiology market scenario for the current period and forecast timeline of 2020-2027The global Interventional Cardiology Market is expected to reach USD 26.92 Billion by 2027, according to a new report by Emergen Research.

The growth of this market can be attributed to the increasing initiatives of the government to improve the healthcare infrastructure with advanced diagnostic solutions.

The government has increased the allocation of healthcare budgetary in developing countries, and it has also introduced several reimbursement policies to encourage the adoption of technologically advanced interventional cardiology devices.Market Dynamics:The report offers insightful information about the market dynamics of the Interventional Cardiology market.

It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Interventional Cardiology market, competitive landscape, factors affecting it, and to predict the growth of the industry.